[PDF] Artificial Heart Lung Machines Market | Grow to Huge Growth in Future Scope between 2022-2029
Artificial heart-lung machines, also known as cardiopulmonary bypass machines, are medical devices that temporarily take over the function of the heart and lungs during surgery. These machines are used in a variety of surgical procedures, such as open-heart surgery, lung transplantation, and other procedures that require stopping the heart or interrupting blood flow to the heart and lungs.
The artificial heart-lung machine works by diverting blood from the heart and lungs through a pump, which oxygenates and circulates the blood back into the patient’s body. This allows the surgeon to perform surgery on a non-beating heart, or to temporarily stop blood flow to the heart and lungs without compromising the patient’s overall oxygen supply. The market for artificial heart-lung machines is driven by the growing number of cardiac surgeries and lung transplantations being performed worldwide, as well as the increasing prevalence of cardiovascular diseases. Advances in technology, such as the development of portable and miniaturized machines, have also contributed to the growth of the market.
Some of the key players in the artificial heart-lung machines market include Medtronic, Sorin Group, Terumo Corporation, LivaNova PLC, and Maquet Holding B.V. As the demand for these devices continues to increase, competition among these companies is expected to intensify, leading to the development of new and improved technologies.
Get Sample Copy of Report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2793
Artificial Heart Lung Machines Market key points:
‣ Growing incidence of cardiovascular diseases: The prevalence of cardiovascular diseases, such as coronary artery disease and heart failure, is on the rise globally, which is leading to an increase in the number of cardiac surgeries being performed.
‣ Rising demand for lung transplantation: The demand for lung transplantation is also increasing, especially for patients with end-stage lung diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).
‣ Technological advancements: The development of portable and miniaturized machines has made it easier for healthcare professionals to perform surgeries in remote areas and in emergency situations.
‣ High cost of equipment: Artificial heart-lung machines are expensive, which can limit their adoption in certain regions and by some healthcare facilities.
‣ Competition among key players: The market is highly competitive, with major players investing in R&D activities to develop new and innovative technologies to stay ahead of their competitors.
Market segmentation:
By Type:
➣ Single Roller Pump
➣ Double Roller Pump
By Application:
➣ Cardiac Surgery
➣ Lung Transplantation Operations
➣ Acute Respiratory Failure Treatment
Regional scope:
- North America– U.S., Canada
- Europe– UK, Germany, Spain, France, Italy, Russia, Rest of Europe
- Asia Pacific– Japan, India, China, South Korea, Australia, Rest of Asia-Pacific
- Latin America– Brazil, Mexico, Argentina, Rest of Latin America
- Middle East & Africa– South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Get Sample PDF Copy of Report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/2793
- FORMAT:PDF
- NO OF PAGES:170
- BASE YEAR:2019
Key Players:
- Medtronic Inc.
- Sorin Group
- MAQUET GmbH & Co. KG
- Terumo Corporation
- Bard, Inc.
- Edwards Lifesciences LLC
- Braile Biomedica, Inc.
- Tianjin Medical
- SynCardia Systems, Inc.
- Jarvik Heart, Inc.
Analyst View of Artificial Heart Lung Machines Market:
Artificial heart-lung machines market is expected to witness significant growth in the coming years due to factors such as the rising incidence of cardiovascular diseases, increasing demand for lung transplantation, and technological advancements in the field. The market is highly competitive, with major players investing in R&D activities to develop new and innovative technologies. However, the high cost of equipment can limit its adoption in certain regions and by some healthcare facilities.
Geographically, North America and Europe are expected to dominate the market due to the high prevalence of cardiovascular diseases in these regions and the presence of advanced healthcare infrastructure. Asia-Pacific is expected to witness significant growth due to increasing government initiatives to improve healthcare infrastructure and rising awareness about the benefits of artificial heart-lung machines.
Overall, the artificial heart-lung machines market is expected to continue growing as the demand for cardiac surgeries and lung transplantation increases worldwide, and as technology continues to advance, leading to the development of new and improved devices.
Key questions of Artificial Heart Lung Machines Market:
- What is the current market size and growth rate of the artificial heart-lung machines market?
- What are the major factors driving the growth of the market, and what are the challenges faced by the industry?
- Which regions or countries are expected to dominate the market in terms of revenue and growth rate?
- What are the key trends and developments in the artificial heart-lung machines market?
- Who are the major players in the market, and what are their market shares and strategies?
To know more
Contact Us:
Sales
Prophecy Market Insights
+1 860 531 2574
Email– sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com
Follow us on:
